AIDSmeds Founder Peter Staley interviewed Dr. Joe Eron from the University of North Carolina in Chapel Hill and lead investigator of KLEAN, a large trial that showed, for the first time, that another protease inhibitor (Lexiva) is "equivalent" to Kaletra, the current standard of care.
Click here to listen to the 10 minute interview. (8.9 MB mp3 file)
If you don't understand one of the words in this article,
just double-click it. A window will open with a definition
from CancerWEB's On-line Medical Dictionary. If the double-click feature
doesn't work in your browser, you can enter the word below:
